| Molecular modulators of celastrol as the keystones for its diverse pharmacological activities SW Ng, Y Chan, DK Chellappan, T Madheswaran, F Zeeshan, YL Chan, ... Biomedicine & Pharmacotherapy 109, 1785-1792, 2019 | 84 | 2019 |
| Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics YY Tan, PK Yap, GLX Lim, M Mehta, Y Chan, SW Ng, DN Kapoor, P Negi, ... Chemico-Biological Interactions 329, 109221, 2020 | 56 | 2020 |
| Celastrol-loaded liquid crystalline nanoparticles as an anti-inflammatory intervention for the treatment of asthma Y Chan, SW Ng, DK Chellappan, T Madheswaran, F Zeeshan, P Kumar, ... International Journal of Polymeric Materials and Polymeric Biomaterials 70 …, 2021 | 36 | 2021 |
| Renal Nano-drug delivery for acute kidney Injury: Current status and future perspectives HN Geo, DD Murugan, Z Chik, A Norazit, YY Foo, BF Leo, YY Teo, ... Journal of Controlled Release 343, 237-254, 2022 | 35 | 2022 |
| Superhydrophobic Nanocoatings as Intervention against Biofilm-Associated Bacterial Infections Y Chan, XH Wu, BW Chieng, NA Ibrahim, YY Then Nanomaterials 11 (4), 1046, 2021 | 32 | 2021 |
| Versatility of liquid crystalline nanoparticles in inflammatory lung diseases Y Chan, M Mehta, KR Paudel, T Madheswaran, J Panneerselvam, ... Nanomedicine 16 (18), 1545-1548, 2021 | 29 | 2021 |
| Nutraceuticals: Unlocking newer paradigms in the mitigation of inflammatory lung diseases Y Chan, VSR Raju Allam, KR Paudel, SK Singh, M Gulati, ... Critical reviews in food science and nutrition 63 (19), 3302-3332, 2023 | 26 | 2023 |
| Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanisms Y Chan, SW Ng, JZX Tan, G Gupta, MM Tambuwala, HA Bakshi, H Dureja, ... Chemico-Biological Interactions 315, 108911, 2020 | 26 | 2020 |
| Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis Y Chan, SW Ng, M Mehta, K Anand, SK Singh, G Gupta, DK Chellappan, ... Medical Hypotheses 144, 110298, 2020 | 23 | 2020 |
| Rediscovering the Therapeutic Potential of Agarwood in the Management of Chronic Inflammatory Diseases JMR Alamil, KR Paudel, Y Chan, D Xenaki, J Panneerselvam, SK Singh, ... Molecules 27 (9), 3038, 2022 | 19 | 2022 |
| Nutraceuticals and COVID‐19: A mechanistic approach toward attenuating the disease complications KR Paudel, V Patel, S Vishwas, S Gupta, S Sharma, Y Chan, NK Jha, ... Journal of Food Biochemistry, e14445, 2022 | 18 | 2022 |
| Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis N Verma, V Arora, R Awasthi, Y Chan, NK Jha, K Thapa, T Jawaid, ... Journal of Drug Delivery Science and Technology 75, 103690, 2022 | 18 | 2022 |
| Bioactive Compounds from Zingiber montanum and Their Pharmacological Activities with Focus on Zerumbone HP Devkota, KR Paudel, M Hassan, AI Dirar, N Das, A Adhikari-Devkota, ... Applied Sciences 11 (21), 10205, 2021 | 18 | 2021 |
| Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems P Prasher, M Sharma, SK Singh, M Gulati, NK Jha, PK Gupta, G Gupta, ... Chemico-Biological Interactions 365, 110048, 2022 | 15 | 2022 |
| Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models CL Tan, Y Chan, M Candasamy, J Chellian, T Madheswaran, ... European Journal of Pharmacology 919, 174821, 2022 | 15 | 2022 |
| Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective Y Chan, SW Ng, SK Singh, M Gulati, G Gupta, SK Chaudhary, GB Hing, ... Life Sciences 280, 119744, 2021 | 12 | 2021 |
| Natural products in the management of obesity: Fundamental mechanisms and pharmacotherapy Y Chan, SW Ng, JZX Tan, G Gupta, P Negi, L Thangavelu, SR Balusamy, ... South African Journal of Botany 143, 176-197, 2021 | 9 | 2021 |
| Plant-Based Chemical Moieties for Targeting Chronic Respiratory Diseases Y Chan, SW Ng, K Dua, DK Chellappan Targeting Cellular Signalling Pathways in Lung Diseases, 741-781, 2021 | 9 | 2021 |
| Applications and practice of advanced drug delivery systems for targeting Toll-like receptors in pulmonary diseases Y Chan, P Prasher, R Löbenberg, G Gupta, SK Singh, BG Oliver, ... Nanomedicine 16 (10), 783-786, 2021 | 8 | 2021 |
| Sugar-based nanoparticles for respiratory diseases: a new paradigm in the nanoworld Y Chan, SW Ng, M Mehta, G Gupta, DK Chellappan, K Dua Future Medicinal Chemistry 12 (21), 1887-1890, 2020 | 7 | 2020 |
Dinesh Kumar ChellappanAssociate Professor in Life Sciences, International Medical University, MalaysiaVerified email at imu.edu.my
